GLSI6:00 AMGreenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027greenwichlifesciences.com
GLSI6:00 AMGreenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United KingdomTrial Design Update • Phase 3greenwichlifesciences.com
GLSI6:00 AMGreenwich LifeSciences Provides Clinical Updates on FLAMINGO-01Trial Design Update • Phase 3greenwichlifesciences.com
GLSI7:30 AMGreenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01Trial Design Update • Phase 3greenwichlifesciences.com
GLSI6:00 AMGreenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01greenwichlifesciences.com